FDA Warning Letter — Henan Lihua Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Henan Lihua Pharmaceutical Co., Ltd. on June 12, 2018 (Anyang, China). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Henan Lihua Pharmaceutical Co., Ltd.
- Date
- June 12, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Anyang (China)